Biomedical ChemistryChemistry with potential for advancing medical technology and the understanding of disease at the molecular level
|
|
|
|
Exploring pathological mineralization and crystallization in kidney stone formation.
The Ward laboratory explores the mechanisms responsible for the pathogenesis of kidney stones. Using atomic force microscopy (AFM), the role of urinary macromolecules on crystallization of calcium oxalate and cystine, two common ingredients in kidney stones, can be examined in real time under conditions simulating the renal environment. AFM also permits direct measurement of adhesion at different crystal surfaces under these conditions, providing insight into the microscopic events responsible for aggregation of single crystals into stones. For example, osteopontin, a protein known to regulate calcium oxalate stone formation, increases adhesion between calcium oxalate crystal surfaces and carboxylate groups on an AFM tip, suggesting an adhesive role for this protein in stone formation.
|
Biomedical Chemistry
Faculty
|
| Paramjit S Arora
Design and synthesis of peptidomimetics; inhibitors of protein-protein interactions; small molecular ligands for nucleic acids; artificial control of gene expression. |
| |
| James Canary
Design and synthesis of agents for biomedical molecular imaging, fluorescent probes for metal ions relevant to neurobiology, cancer imaging and chemotherapy. |
| |
| John Spencer Evans
Biomimetic or "Nature"-based materials, macromolecule-interfacial interactions, biomineralization, nuclear magnetic resonance spectroscopy, protein structure determination, mass spectrometry, computational chemistry.
|
| |
| Nicholas E. Geacintov
DNA lesions in cancer; mechanisms of DNA modification; structure and properties of damaged DNA |
| |
| Alexej Jerschow
NMR/MRI methods in tissues. MRI markers for osteoarthritis, intervertebral discs, and brain tumors. Contrast agents based on enhanced relaxation and chemical exchange. Molecular imaging. |
| |
| Neville R. Kallenbach
Protein structure function and folding, antimicrobial agents based on peptides of the
innate immune system, model helix and beta-sheet structures; biophysical chemistry of proteins and nucleic acids
|
| |
| Kent Kirshenbaum
Design and synthesis of peptidomimetics; multivalent display; macromolecular design; biomimetic chemistry |
| |
| Tamar Schlick
Molecular mechanics and dynamics, computational and structural biology, DNA supercoiling, RNA structure and genomics, and DNA/protein interactions. Biomolecular Modeling. |
| |
| Nadrian C. Seeman
DNA Nanotechnology, Macromolecular Design and Topology, Biophysical Chemistry of Recombinational Intermediates, DNA-Based Computation and Crystallography |
| |
| Michael D Ward
Materials and solid-state chemistry, microscopic origins of pathological biomineralization and crystals in disease |
| |
| Marcus Weck
Polymeric scaffolds for tissue engineering, drug delivery and imaging |
| |
| Yingkai Zhang
Theoretical chemistry and computational enzymology; ab initio QM/MM and multiscale simulation methods; histone modifications and recognition; and membrane enzymes. |
| |
|
|
|